Stronger modulation of miRNAs was present on re-biopsy in the supplementation group compared to the placebo , including : ( i ) overexpression of miRNAs present in PCa versus non-cancer tissue ; ( ii ) underexpression of miRNAs suppressing PCa proliferation ; ( iii ) detection of 35 miRNAs in PCa patients versus disease-free men , including androgen-regulated miR-125b-5p and PTEN-targeting miR-92a-3p ( both upregulated ) .